These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 12751500)

  • 1. The regulation of home diagnostic tests for genetic disorders: can the FDA deny a premarket application on the basis of the device's social impacts?
    Kerouac JD
    J Biolaw Bus; 2002; 5(1):34-43. PubMed ID: 12751500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Don’t Try This at Home: the FDA’s Restrictive Regulation of Home Testing Devices.
    Baird S
    Duke Law J; 2017 Nov; 67(2):383-426. PubMed ID: 29469551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices: the obvious, the readily-accepted, and the surprising.
    Tolomeo DE; Clarke LA
    J Health Life Sci Law; 2008 Jul; 1(4):117, 119-44. PubMed ID: 18717154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematology and pathology devices; reclassification; restricted devices; OTC test sample collection systems for drugs of abuse testing--FDA. Proposed rule.
    Fed Regist; 1998 Mar; 63(43):10792-8. PubMed ID: 10177743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General and plastic surgery devices; effective date of requirement for premarket approval of the silicone inflatable breast prosthesis. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
    Fed Regist; 1999 Aug; 64(160):45155-61. PubMed ID: 10558602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medtronic, Inc.; premarket approval of the Interstim Sacral Nerve Stimulation (SNS) System--FDA. Notice.
    Fed Regist; 1998 Jan; 63(19):4457. PubMed ID: 10177327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA's role in medical device clinical studies of human subjects.
    Saviola J
    J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of a coherent framework: options for FDA oversight of genetic tests.
    Javitt GH
    Food Drug Law J; 2007; 62(4):617-52. PubMed ID: 18557224
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical devices; effective date of requirement for premarket approval for three class III preamendments devices--FDA. Proposed rule; opportunity to request a change in classification.
    Fed Regist; 1998 Aug; 63(159):44177-81. PubMed ID: 10184983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical device recalls and the FDA approval process.
    Zuckerman DM; Brown P; Nissen SE
    Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental devices; effective date of requirement for premarket approval; temporomandibular joint prostheses--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(250):71743-6. PubMed ID: 10339055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jun; 67(115):40848-9. PubMed ID: 12068899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; effective date of requirement for premarket approval for a class III preamendments obstetrical and gynecological device. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jul; 65(129):41330-2. PubMed ID: 11067678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(72):19833-4. PubMed ID: 11010634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; effective date of requirement for premarket approval for three class III preamendments devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(120):34917-20. PubMed ID: 15224687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.